Literature DB >> 17160377

Vascular endothelial dysfunction in patients with mild obstructive sleep apnea syndrome.

Hans-Werner Duchna1, Riccardo Stoohs, Christian Guilleminault, Marie Christine Anspach, Gerhard Schultze-Werninghaus, Maritta Orth.   

Abstract

BACKGROUND: We investigated endothelial dysfunction, an early manifestation of atherosclerosis, in patients with mild obstructive sleep apnea syndrome (OSAS) (5/h < AHI < 15/h). PATIENTS AND METHODS: Endothelium-dependent and -independent vasodilatory function was tested in 10 patients with mild OSAS, 12 healthy controls and 20 subjects with moderate to severe OSAS using the hand vein compliance technique.
RESULTS: Maximum endothelium-dependent vasodilation to bradykinin (Emax) was significantly blunted in patients with mild OSAS (68.6 +/- 30.2 %) compared to healthy controls (94.8 +/- 9.5 %; p < 0.05; moderate to severe OSAS: 57.1 +/- 23.4 %; p = 0.33). Mean endothelium-independent venodilation was not altered. After 160.7 +/- 82.2 nights of CPAP therapy, mean Emax was significantly improved to 90.8 +/- 23.8 % (p < 0.01 vs. baseline; p = 0.7 vs. healthy controls) in 7 patients with mild OSAS.
CONCLUSIONS: Systemic endothelium-dependent venodilation is markedly reduced in subjects with mild OSAS, which may imply adverse cardiovascular consequences. CPAP-treatment leads to a sustained restoration of endothelial dysfunction in these patients and is thus highly recommended.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160377     DOI: 10.1007/s10354-006-0341-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  37 in total

1.  Vascular reactivity in obstructive sleep apnea syndrome.

Authors:  H W Duchna; C Guilleminault; R A Stoohs; J L Faul; H Moreno; B B Hoffman; T F Blaschke
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

2.  Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy.

Authors:  Virginia A Imadojemu; Kevin Gleeson; Sadeq A Quraishi; Allen R Kunselman; Lawrence I Sinoway; Urs A Leuenberger
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

3.  Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome.

Authors:  Hans-W Duchna; Maritta Orth; Gerhard Schultze-Werninghaus; Christian Guilleminault; Riccardo A Stoohs
Journal:  Sleep Breath       Date:  2005-09       Impact factor: 2.816

4.  Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. American Sleep Disorders Association.

Authors: 
Journal:  Sleep       Date:  1995-07       Impact factor: 5.849

5.  Early signs of atherosclerosis in obstructive sleep apnea.

Authors:  Luciano F Drager; Luiz A Bortolotto; Maria Cecília Lorenzi; Adelaide C Figueiredo; Eduardo M Krieger; Geraldo Lorenzi-Filho
Journal:  Am J Respir Crit Care Med       Date:  2005-05-18       Impact factor: 21.405

6.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

Review 7.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

Review 9.  Clinical pharmacology, physiology and pathophysiology of superficial veins--1.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

Review 10.  Obstructive sleep apnea: implications for cardiac and vascular disease.

Authors:  Abu S M Shamsuzzaman; Bernard J Gersh; Virend K Somers
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

View more
  8 in total

1.  Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia.

Authors:  Ronghua Yang; Gautam Sikka; Jill Larson; Vabren L Watts; Xiaolin Niu; Carla L Ellis; Karen L Miller; Andre Camara; Christian Reinke; Vladimir Savransky; Vsevolod Y Polotsky; Christopher P O'Donnell; Dan E Berkowitz; Lili A Barouch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-28       Impact factor: 4.733

2.  Mild obstructive sleep apnea syndrome should be treated. Pro.

Authors:  Lee K Brown
Journal:  J Clin Sleep Med       Date:  2007-04-15       Impact factor: 4.062

3.  Circadian variability of fibrinolytic markers and endothelial function in patients with obstructive sleep apnea.

Authors:  Kanika Bagai; James A S Muldowney; Yanna Song; Lily Wang; Jayant Bagai; Kay J Artibee; Douglas E Vaughan; Beth A Malow
Journal:  Sleep       Date:  2014-02-01       Impact factor: 5.849

4.  The relationship between diurnal variation of cytokines and symptom expression in mild obstructive sleep apnea.

Authors:  Hyunju Yang; Christopher G Engeland; Tonya S King; Amy M Sawyer
Journal:  J Clin Sleep Med       Date:  2020-02-07       Impact factor: 4.062

5.  Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment.

Authors:  Maria Del Ben; Mario Fabiani; Lorenzo Loffredo; Licia Polimeni; Roberto Carnevale; Francesco Baratta; Marco Brunori; Fabiana Albanese; Teresa Augelletti; Francesco Violi; Francesco Angelico
Journal:  BMC Pulm Med       Date:  2012-07-23       Impact factor: 3.317

6.  The treatment of mild OSA with CPAP or mandibular advancement device and the effect on blood pressure and endothelial function after one year of treatment.

Authors:  Thais Moura Guimarães; Dalva Poyares; Luciana Oliveira E Silva; Gabriela Luz; Glaury Coelho; Cibele Dal Fabbro; Sergio Tufik; Lia Bittencourt
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

Review 7.  Obstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approaches.

Authors:  Wang Zhang; Liang-yi Si
Journal:  Ups J Med Sci       Date:  2012-09-25       Impact factor: 2.384

8.  Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway.

Authors:  Jie-Ru Li; Ya-Shuo Zhao; Yue Chang; Sheng-Chang Yang; Ya-Jing Guo; En-Sheng Ji
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.